Morning Consult study inspires Zoom’s “Hard Stop Burger Shop” pop-up in NYC, highlighting how AI automation can reduce meeting overload and restore balance to the workday NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) — Today, Zoom Communications Inc. (NASDAQ: ZM)
Outdoor Digital Art Projection and City Art Walks Bring World‑Class Artistic Elements into Local Neighbourhoods HONG KONG, March 25, 2026 (GLOBE NEWSWIRE) — Riding on the wave of a spectacular line‑up of mega events throughout March and April, the Hong
SEOUL, South Korea, March 25, 2026 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced that it is providing enterprise-grade data center infrastructure to Samsung Electronics at its ICN10 data center
Kymeta launches Kestrel u5 terminal Kymeta announces new Kestrel u5 – the smallest and most capable multi-orbit SATCOM terminal designed for the unmanned systems, national security and high-speed industrial mobility operations New multi-orbit SATCOM terminal expands capabilities for autonomous,
Radiation-Hardened SSD and Space-Grade SSD by Foremay Formeay’s Rad-Hard SSD and Space-Grade SSD for LEO, MEO, GEO, HEO and deep space applications. The industry’s first NVMe and SATA Rad-Hard SSD engineered for missions ranging from LEO to deep space, featuring
CGTN published an article exploring Xiongan New Area’s transformation into a modern urban model, highlighting the success of orderly relocation of Beijing’s non-capital functions as the core driver. It emphasizes human-centered achievements through massive investment, policy guarantees, and integration measures.
AFI AFI COPENHAGEN, Denmark, March 22, 2026 (GLOBE NEWSWIRE) — A clinical study published in Nutrients has shown that infant formula containing Arla Foods Ingredients’ Lacprodan® IF-3070 was well tolerated in infants, with growth and development indicators remaining within an appropriate range.1 The findings provide
ALBANY, N.Y., March 19, 2026 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as enhancements to its proprietary platform
